Miromatrix Medical Inc. (NASDAQ:MIRO – Get Rating) saw a large drop in short interest in April. As of April 15th, there was short interest totalling 459,800 shares, a drop of 6.5% from the March 31st total of 491,800 shares. Based on an average daily volume of 56,400 shares, the short-interest ratio is currently 8.2 days. […]
Miromatrix Medical Inc. (NASDAQ:MIRO – Get Rating) saw a large decline in short interest in April. As of April 15th, there was short interest totalling 459,800 shares, a decline of 6.5% from the March 31st total of 491,800 shares. Currently, 1.8% of the shares of the stock are sold short. Based on an average daily […]
EDEN PRAIRIE, Minn., April 27, 2023 (GLOBE NEWSWIRE) Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for.
Miromatrix Medical (NASDAQ:MIRO – Get Rating) and Caribou Biosciences (NASDAQ:CRBU – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends and earnings. Earnings & Valuation This table compares Miromatrix Medical and […]
Miromatrix Medical (NASDAQ:MIRO – Get Rating) and BioCryst Pharmaceuticals (NASDAQ:BCRX – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, analyst recommendations, profitability, risk and dividends. Risk and Volatility Miromatrix Medical has a beta of […]